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Abstract
Mutations in the TRPS1 gene lead to the tricho-rhino-phalangeal syndrome, which is characterized by skeletal defects and abnormal hair
development. The TRPS1 gene encodes an atypical member of the GATA-type family of transcription factors. Here we show that mice with a
disrupted Trps1 gene develop a chondrodysplasia characterized by diminished chondrocyte proliferation and decreased apoptosis in growth plates.
Our analyses revealed that Trps1 is a repressor of Stat3 expression, which in turn controls chondrocyte proliferation and survival by regulating the
expression of cyclin D1 and Bcl2. Our conclusion is supported (i) by siRNA-mediated depletion of Stat3 in Trps1-deficient chondrocytes, which
normalized the expression of cyclin D1 and Bcl2, (ii) by overexpression of Trps1 in ATDC5 chondrocytes, which diminished Stat3 levels and
increased proliferation and apoptosis, and (iii) by mutational analysis of the GATA-binding sites in the Stat3 gene, which revealed that their
integrity is critical for the direct association with Trps1 and for Trps1-mediated repression of Stat3. Altogether our findings identify Trps1 as a
novel regulator of chondrocytes proliferation and survival through the control of Stat3 expression.
© 2007 Elsevier Inc. All rights reserved.Keywords: Trps1; Stat3; Chondrocytes; Growth plate; Apoptosis; ProliferationIntroduction
Tricho-rhino-phalangeal syndrome type I and type III (TRPS
I or TRPS III) is an autosomal dominant skeletal disorder
characterized by short stature and craniofacial anomalies such
as a bulbous tip of the nose, a flat and long philtrum, protruding
ears and sparse scalp hair (Giedion et al., 1973; Niikawa and
Kamei, 1986). TRPS III is more severe than TRPS I and in
addition shows brachydactyly (Itin et al., 1996; Nagai et al.,
1994). The cause for TRPS I and IIII are mutations in the
TRPS1 gene, which encodes a transcription factor composed of
9 zinc-finger domains, including a single GATA-type DNA
binding domain flanked by two potential nuclear localization⁎ Corresponding author. Fax: +81 73 446 3781.
E-mail address: ymuragak@wakayama-med.ac.jp (Y. Muragaki).
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doi:10.1016/j.ydbio.2007.10.001signals (NLS), and two C-terminal zinc fingers closely related to
a domain found in the Ikaros family of lymphoid transcription
factors (Momeni et al., 2000). Genotype analysis of patients
affected with TRPS identified premature stop mutations in the
N-terminal half of TRPS1 leading to truncated proteins,
mutations in the GATA binding domain, and in the NLS
preventing translocation of TRPS1 into the nucleus (Kaiser
et al., 2003b; Ludecke et al., 2001; Momeni et al., 2000). In line
with the affected organs of patients TRPS1 is highly expressed
in cartilage, developing joints, hair follicles and in the nasal
region (Abu et al., 1997; Malik et al., 2001; Kunath et al., 2002).
Further support for TRPS1 as disease causing gene comes from
gene deletion studies in mice. Mice heterozygous for a deletion
of GATA domain in the Trps1 gene develop thoracic
kyphoscoliosis and have structural deficits in cortical and
trabecular bones (Malik et al., 2002). Homozygous mice lack
vibrissae, have reduced hair follicles and die perinatally due to
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spine and ribs (Malik et al., 2002). The molecular defects
leading to the abnormalities both in human patients and in mice
are not known.
TRPS1 is exclusively found in the nucleus and behaves as a
potent, sequence-specific transcriptional repressor in vitro and
in vivo. It has been shown that the repressive activity depends
on the C-terminal region related to repressive domains found in
Ikaros proteins (Malik et al., 2001). Yeast 2-hybrid assays
demonstrated that TRPS1 can interact with the light chain 8
protein (LC8a) (Kaiser et al., 2003b) and the ring finger protein
RNF4 (Kaiser et al., 2003a). LC8a is usually involved in
cytoplasmic transport processes but was shown to co-localize
with TRPS1 in distinct, ill-defined structures of the cell nucleus.
RNF4 is a transcriptional co-regulator of several genes and is
found to be distributed diffusely throughout the cytoplasm and
in numerous small granules within the nucleus. DNA binding
assays and reporter studies revealed that binding of TRPS1 with
either LC8a or RNF4 diminishes the interaction of TRPS1 to
GATA consensus sequences and as a consequence releases the
repressor activity of TRPS1.
Prior to the implication of TRPS1 in the etiology of TRPS,
Chang et al. (1997) isolated the protein from androgen-
dependent prostate carcinoma cells and termed it GC79. Their
studies proposed that GC79/TRPS1 is repressed by androgens
and is involved in apoptosis of prostate cells (Chang et al., 1997,
2002). In vivo depletion of androgens by castration leads to
increased expression of TRPS1 in the prostate and concomi-
tantly to apoptosis of prostate cells and regression of the organ
(Chang et al., 2002). How androgens repress TRPS1 expression
and how TRPS1 induces apoptosis of prostate cells is unclear.
To gain mechanistic insights into TRPS1 function we
generated mice carrying a null mutation in the Trps1 gene and
found that their growth plate chondrocytes display impaired
proliferation and decreased apoptosis caused by increased
expression and activation of Stat3.
Materials and methods
Generation of Trps1-null mice
The mouse Trps1 gene was cloned from a 129/Sv genomic library (UK
HGMP Resource Center, Hinxton, UK). The targeting vector consisted of 2.5 kb
of 5′ homology followed by an internal ribosomal entry site (IRES)-β-
galactosidase gene, the neomycin resistance gene and 8.5 kb of 3′ homology.
The targeting vector was linearized and electroporated into R1 embryonic stem
(ES) cells (Fassler and Meyer, 1995). Homologous recombination was analyzed
by Southern blot using BamHI-digested genomic DNA extracted from ES cell
clones. Homologous recombinant clones showed a band of 11 kb in addition to
the 15-kb wild-type band. Targeted ES cells were injected into C57BL/6
blastocysts and transferred into uteri of BDF1 pseudopregnant females.
Chimeric males were mated with C57BL/6 females.
Production of Trps1-specific antibody
A 1002-bp-long cDNA, coding for 333 amino acid residues of the carboxyl
end of Trps1, was cloned in the His-tag containing pQE31 (QIAGEN). The
bacterially expressed protein was affinity purified using a nickel column and
used to immunize rabbits. Immunization was repeated three times in 2-week
intervals.Histology, immunostaining and in situ hybridization
Whole skeletons of newborn mice were stained with Alcian blue and
Alizarin red as described previously (Aszodi et al., 1998). Limbs were removed
from newborn mice, fixed in 4% paraformaldehyde overnight at 4 °C, and
embedded in Tissue-Tek (Sakura Finetechnical Co., Ltd.) at −130 °C. Frozen
sections were cut 5 μm thick and stained with hematoxylin/eosin (HE). For
immunostaining, limbs and bronchi were removed from newborn mice and
embedded in OCTcompound at −130 °C without prior fixation. Frozen sections
were cut 5 μm thick, incubated with antibodies against Trps1, phosphorylated
Stat3, washed in PBS, incubated with secondary antibodies, and finally mounted
in VECTA SHIELD Mounting Medium (Vector Laboratories, Inc.) with DAPI.
LacZ staining was performed both in whole mount and in section as previously
described (Sakai et al., 2001).
For in situ hybridization digoxygenin (DIG)-labeled sense and antisense
cRNA probes were generated from plasmids containing mouse Col2a1,
Col10a1, PTH/PTHrP receptor (Ppr), and Indian hedgehog (Ihh) cDNAs
using a digoxygenin labeling kit according to the instructions (La Roche). Cryo-
sections were hybridized at 50 °C overnight. After stringent washes, the sections
were reacted with an alkaline phosphatase-labeled anti-DIG antibody (La
Roche). After rinses with Tris-buffered saline (TBS) solution, the sections were
developed with BICP/NTB and subsequently mounted.
Overexpression of Trps1 and Stat3-C in ATDC5 cells
A full-length cDNA encoding Trps1 was subcloned in pcDNA3.1 (+)
(Invitrogen). The linearized DNA was electroporated into ATDC5 cells
(obtained from RIKEN cell bank) and cultured in D/F12 medium (Gibco
BRL) containing 10% FBS, 3×10−8 M transferrin, and 10 μg/ml sodium
selenite and selected with G418 (Sigma). To differentiate ATDC5 cells into
chondrocytes, they were treated for 7 days with 10 μg/ml of insulin. ATDC5
cells transfected with a pcDNA3.1 vector only were served as control. To
overexpress Stat3, adenovirus encoding a constitutively activated Stat3
(Stat3-C) was transduced into ATDC5 cells. Cells were harvested 7 days after
insulin treatment for differentiation.
Knockdown of Stat3 in Trps1-deficient chondrocytes
Synthesized double-strand siRNA oligonucleotides encoding Stat3 were
purchased from Invitrogen. Lipofectamine 2000 (Invitrogen) was used as the
transfection reagent together with 200 nmol of siRNA following manufacture's
directions. Cells were incubated for 6 h and then cultured with media
supplemented with 10% FCS. 96 h after transfection, cells were harvested, lysed
and assayed by Western blot analysis. Stealth double-strand siRNAwas used as
a negative control.
Western blotting
ATDC5 cells or isolated primary chondrocytes, respectively, were lysed on
ice in RIPA buffer. Lysates were mixed with reducing sample buffer, boiled,
separated by SDS-PAGE and blotted on nitrocellulose membranes (S&S) or
PVDF membranes (Millipore). The membranes were blocked with TBS
containing 0.1% Tween20 and 5% BSA at room temperature for 1 h and
finally incubated with primary antibodies at 4 °C overnight. Subsequently the
blots were washed with TBS containing 0.1% Tween20, then treated with
horseradish peroxidase-conjugated secondary antibodies at room temperature
for 1 h and developed with the ECL detection system (Amersham Bioscience).
Antibodies used were specific for cyclin D1 (Medical and Biological
Laboratories), Bcl-2 (Santa Cruz Biotechnologies), cleaved caspase-3, Stat3,
and phosphorylated Stat3 (Cell Signaling Technology).
Detection of BrdU labeling and apoptotic cells
To identify proliferating cells in tissue sections, pregnant females were
injected intraperitoneally with 10 mg/ml BrdU (Sigma) 2 h prior to sacrifice.
Sections were prepared as described above and treated with a monoclonal anti-
BrdU antibody (Boehinger Mannheim) and Envision (Dako) for secondary
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D-MEM/F12 medium (GIBCO BRL) supplemented with 5% FBS (MBL),
10 μg/ml transferrin (Sigma) and 3×10−8 M sodium selenite (Sigma), replacing
culture medium every other day. For determining cell proliferation in ATDC5
cells, Cell Proliferation ELISA system (Amersham) was used according to the
manufacturer's recommendation. Apoptotic cells were identified with the
TUNEL (terminal deoxynucleotidyl transferase mediated dUTP nick end
labeling) method using ApopTag peroxidase and Fluorescein in situ apoptosis
detection kits (INTERGEN). To induce apoptosis of cultured ATDC5 cells and
primary chondrocytes, 0.3 μg/ml Jo2, an agonistic antibody to Fas, and
1.5 μg/ml cyclohexamide were added into the culture medium 48 h prior to the
experiments.
Luciferase assay
A 1216-bp fragment corresponding to nucleotides −1178 to +38 of the
murine Stat3 promoter was amplified from mouse genomic DNA and subcloned
into the pGL3-Basic luciferase reporter vector (Promega). The fragment was
inserted into the KpnI–XhoI site upstream of the luciferase gene of the pGL3-
Basic vector.
Transfections of 0.5×105 chondrocytes were carried out with varying
amounts of the reporter construct using LipofectAMINE (Invitrogen) according
to the manufacture's recommendations. The cells were harvested 24 h after
transfection and assayed for both renilla and firefly luciferase activity by using a
Dual Lusiferase kit (Promega). Co-transfection of 1 μg of pcDNA-rLUC (renilla
luciferase) was used as optimized equalization control. Transfections of the
constructs were performed independently and in triplicate.
Site-directed mutagenesis
Site-directed mutagenesis of GATA sites in the Stat3 promoter was
performed using QuickChange Site-Directed Mutagenesis Kit (Stratagene)
according to the manufacture's recommendations. Briefly, PCR primers
encompassing the GATA sites in the Stat3 promoter (−1059 to −1056 and
−558 to −555) and flanking sequences were used. The upstream GATA
substituted by the GAGA sequence (mutation underlined): 5′-CAAGACGT-
GAAATAGGTCAGAGAATTTCAAGAGCGTCAAGAC-3′ and 5′-
GTCTTGACGCTCTTGAAATTCTCTGACCTATTTCACGTCTTG-3′, and
the downstream GATA was substituted with the TAGC sequence (reverse
compliment of TATC, mutation underlined): 5′-GAAACAAGTTGGTCAA-
AACTAGCTTTCAGAATTTCAAGACCC-3′ and 5′-GGGTCTTGAAATTCT-
GAAAGCTAGTTTTGACCAACTTGTTTC-3′. The PCR was performed with
Pfu Turbo polymerase (Stratagene) using the wild-type Stat3 promoter luciferase
construct as template. The PCR reaction was digested with DpnI, and the
undigested plasmids were transformed into One-shot TOP 10 bacteria.
Individual plasmid preparations were sequenced to verify the mutations of the
GATA sites.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as described by (Ogasawara et al., 2004). Briefly,
chondrocytes were prepared from E18.5 wild-type and mutant epiphyseal
cartilage. The cells were fixed with 1% formaldehyde in DMEM at 37 °C for
15 min and then washed with PBS. The cells were resuspended and incubated on
ice for 10 min in 2 ml of lysis buffer containing 1% SDS, 10 mM EDTA, 50 mM
Tris–HCl, pH8.1, 1 mM PMSF, and 1 μg/ml of aprotinin. The cell lysates were
sonicated on ice to fragment the chromosomal DNA. After centrifugation, the
supernatants were diluted with dilution buffer containing 0.01% SDS, 1.1%
TritonX-100, 1.2 mM EDTA, 16.7 mM Tris–HCl, pH 8.1, 167 mMNaCl, 1 mM
PMSF, and 1 μg/ml of aprotinin and were pretreated with a 50% protein G–
sepharose at 4 °C for 4 h to avoid a non-specific binding of chromatin to the
protein G–sepharose. After a brief centrifugation, the supernatants were
incubated with an anti-Trps1 antibody or a control IgG at 4 °C overnight. A
50% protein G–sepharose was then added to the supernatant to allow binding of
immunocomplexes to bind protein G–sepharose at 4 °C for 4 h. After washing
with low-salt (20 mM Tris–HCl, pH 8.1, 150 mM NaCl, 2 mM EDTA, 0.1%
SDS, 1% Triton X-100), high-salt (20 mM Tris–HCl, pH 8.1, 500 mM NaCl,2 mM EDTA, 0.1% SDS, 1% Triton X-100), LiCl (0.25 M LiCl, 10 mM Tris–
HCl, pH 8.1, 1 mM EDTA, 1% sodium deoxycholate, 1% NP40), and TE
(10 mM Tris–HCl, pH 8.0, 1 mM EDTA, pH 8.0) wash buffer in sequential
order, the protein G-bound immunocomplexes were resuspended in 250 μl of
elution buffer (1% SDS, 0.1 M NaHCO3) and the eluates were heated at 65 °C
for 6 h to reverse cross-linking. To remove proteins bound to DNA, the eluates
were treated with proteinase K and the DNAwas precipitated with ethanol after
purification with phenol–chloroform. The Stat3 promoter sequence was
amplified by 35 PCR cycles with the following primers: 5′-CTGTACTCC-
CAACATACAAGACGTG-3′ and 5′-GCTAACACACACAGAGA-
GAAAGCCC-3′ (positions −1094 to −846), and 5′-AGACCCCAGAGTG-
GAGTTACAAATG-3′ and 5′-CTGACACGAATACACAGTACTTGGC-3′
(positions −718 to −465) (Shi et al., 1996).
Results
Trps1-null mice die from respiratory failure and suffer from
chondrodysplasia
To inactivate the Trps1 gene part of exon 3 and intron 3 was
replaced by an IRES-β-galactosidase and neomycin cassettes
(Fig. 1A). Two independently targeted ES cell clones were used
to generate heterozygous (Trps1+/−) mice, which were fertile
and had no apparent phenotype except that they frequently
developed scarce fur on their back at the age of 6–8 months
(data not shown). Homozygous (Trps1−/−) mice were born at
the expected Mendelian distribution (Fig. 1B). Immunohisto-
chemistry of limb sections with Trps1-specific polyclonal
antisera confirmed that mutant mice lack Trps1 expression.
While wild-type joint surfaces showed strong expression, Trps1
signals were absent from digits of Trps1−/− mice (Fig. 1C).
LacZ staining overlapped with the antibody staining in digits of
heterozygous mice indicating that the β-galactosidase gene is
faithfully controlled by the Trps1 promoter (Fig. 1D).
Homozygous mice were dwarfed and began labored
respiration after birth, became cyanotic and finally died of
respiratory distress. Lungs derived from homozygous mutant
mice were smaller than those of wild type and showed reduced
air space with thickened septae in light microscopy. The trachea
from homozygous Trps1-deficient mice was normally sized but
contained abnormal cartilage plates consisting of small
chondrocyte nests instead of a fused cartilage ring (Supple-
mentary Fig. 1). The small cartilage nodules led to a collapse of
the bronchial lumen with severe narrowing of the air space.
Trps1−/− mice showed severe hair follicle abnormalities
and growth retardation. To determine the reason(s) for the
growth retardation, we performed whole-mount skeletal
staining with Alizarin red for bones and Alcian blue for
cartilage (Fig. 1E). Trps1−/− mice had shortened maxillary and
mandibular bones, shortened long bones in limbs, and a short,
thin and bifurcated sternum with an abnormally widened rib
cage. The long bones in mutant mice were 85±3% shorter
than those in the wild-type littermates (Fig. 1F). The
calcification of the sternum was reduced, as was the formation
of the primary ossification centres in developing long bones
(Fig. 1F and Supplementary Fig. 2). Approximately 30% of
mutant mice had an extra rib, which was unilaterally attached
to the sternum. The mutant rib cartilage was fragile and easy
to break during preparation. This fragility might cause and/or
Fig. 1. Targeted disruption of mouse Trps1. (A) Structure of wild-type allele, targeting construct, and mutant allele after homologous recombination. Boxes indicate
exons. The location of the fragment used as a probe for Southern blot is shown, as well as the expected sizes of the two BamHI fragments detected for wild-type and
mutant alleles. (B) Southern blot analysis of tail genomic DNA isolated from the progeny of a heterozygous cross. Fragments corresponding to wild-type (15 kb) and
mutant (11 kb) alleles are shown. +/+, wild-type; +/−, heterozygous; −/−, homozygous. (C) Immunofluorescent staining of newborn digits with an anti-Trps1-specific
antibody (red) confirms complete deletion of the Trps1 protein in the mutant mouse (right). Arrows indicate the location of the joints. Nuclei are stained with DAPI.
Scale bar: 50 μm. (D) LacZ staining shows that Trps1-driven β-galactosidase is expressed in the interphalangeal joint. Scale bar: 100 μm. (E) Whole-mount skeletal
staining of newborn wild-type (+/+) and mutant (−/−) mice with Alizarin red S and Alcian blue. Scale bar: 5 mm. (F) Alizarin red S and Alcian blue staining of forelimb
in newborn wild-type (+/+) and mutant (−/−) mice. Scale bar: 1 mm.
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bronchial rings.
Differentiation of Trps1−/− chondrocytes seems normal
Longitudinal growth of bones is controlled by endochondral
ossification, which occurs in growth plates. Immunohistochem-
istry revealed that Trps1 was present in the articular,
proliferative and prehypertrophic chondrocytes (Fig. 2A)
suggesting that Trps1 exerts an autonomous function in growth
plates.
Alizarin red/Alcian blue staining of the Trps1−/− tibia
revealed a narrow epiphyseal cartilage, which was, however,
longer than in the wild-type tibia (Fig. 2B). Histological
sections showed an extended length of proliferative zone in
Trps1−/− growth plates (Fig. 2C) with a reduced chondrocyte
density (see blow up of Fig. 2C). The cell densities per 10 mm2
were reduced by 30% in the proliferative zone in Trps1−/−
growth plates when compared with growth plates from control
littermates (Fig. 2D). These findings indicate that Trps1 controls
chondrocyte number and, similarly like in the tracheal rings, the
morphology of the growth plate.To determine whether differentiation of Trps1−/− is altered
we performed in situ hybridization analyses with several
differentiation markers. Neither Col2a1 nor Col10a1 mRNA
expression differed between wild-type and Trps1−/− growth
plates (Fig. 2E). The expression of Indian hedgehog (Ihh) and
parathyroid hormone/parathyroid hormone-related peptide
receptor (Ppr) was also similar between wild-type and
Trps1−/− growth plates.
Trps1 regulates proliferation of chondrocytes
To test whether the reduced chondrocyte numbers in
Trps1−/− growth plates were caused by a proliferation defect
we measured BrdU incorporation in the epiphyseal cartilage.
The BrdU labeling index was significantly decreased in
Trps1−/− growth plates (Figs. 3A, B). This was further
confirmed byWestern assays, which revealed a strong reduction
in cyclin D1 expression in freshly isolated Trps1−/− chondro-
cytes (Fig. 3C). The amount of cyclin D1 was reduced by 40%
and 20% in Trps1−/− chondrocyte extracts from epiphyseal and
rib cartilage, respectively. Immunohistochemistry of proli-
ferative chondrocytes with an anti-cyclin D1 antibody also
Fig. 2. Chondrocyte differentiation and function in the tibial epiphyseal cartilage. (A) Immunohistochemical localization of Trps1 in the growth plate. The highest
intensity of immunoreaction (red or pink) is seen in the articular and prehypertrophic chondrocytes. Nuclei were stained with DAPI (blue). The length of each zone is
indicated by a line. Re: resting chondrocytes, Pro: proliferating zone, Hy: hypertrophic zone. (B) Alizarin red/Alcian blue staining of the tibia. Bi-directional arrows
and vertical bars represent the width and the length of the growth plates, respectively. Scale bar: 0.5 mm. (C) All sections are stained with hematoxylin and eosin. The
length of the epiphyseal cartilage is longer in Trps1−/− growth plates, the proliferating (Pro) zone is extended. Boxed areas are shown a blow ups. Scale bar: 100 μm.
(D) The comparison of cell density in the proliferating zone. The white and black columns show the number of chondrocytes per 10 mm2 in the proliferating zone of
wild-type (+/+) and Trps1-deficient (−/−) mice, respectively. Five arbitrary areas were selected from the proliferative zone and the number of chondrocytes was
counted. (E) Histological analysis of chondrocyte differentiation by in situ hybridization. The sections from newborn tibia were hybridized with probes specific for
Col2a1, Indian hedgehog (Ihh), Pth/Pthrp receptor (PPR), and Col X, markers for the proliferating, prehypertrophic, and hypertrophic chondrocytes. Each zone of
chondrocytes is positive for the zone-specific marker.
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Trps1−/− proliferative chondrocytes as compared to wild-type
counterparts (Fig. 3D).
Next we investigated whether overexpression of Trps1 is
enhancing chondrocyte proliferation. To this end we trans-
fected a Trps1 expression construct into the ATDC5 chon-
drocyte cell line. Whereas mock-transfected cells expressed
low levels of Trps1, transfection of the Trps1 expression vector
increased Trps1 levels by 4-fold (Fig. 3D). Cells overexpres-
sing Trps1 exhibited a significantly increased BrdU incor-
poration (Fig. 3E) further indicating that Trps1 promotes
chondrocyte proliferation.
Trps1 regulates apoptosis of hypertrophic chondrocytes
Despite the reduced cell proliferation, we observed a normal
sized zone of hypertrophy in growth plates of newborn Trps1−/−
mice (Fig. 2C), raising the question whether chondrocytes were
also protected from apoptosis. Trps1 was shown to executeandrogen-dependent apoptosis (Chang et al., 2000, 2002) and
terminally differentiated, hypertrophic chondrocytes are elimi-
nated by triggering apoptosis (Hatori et al., 1995).
The number of TUNEL-positive hypertrophic chondrocytes
was dramatically reduced in mutant growth plates, while
TUNEL-positive cells were clearly detectable in wild-type
hypertrophic zone (Fig. 4A). Antibody staining for cleaved
caspase-3 also revealed a reduced number of positively stained
cells in mutant growth plates when compared to controls (data
not shown). Western blot analyses further confirmed the
reduced expression of cleaved caspase-3 in chondrocyte lysates
derived from Trps1−/− rib and epiphyseal cartilage (Fig. 5A). In
addition, we found that the expression of Bcl-2 was increased
by at least two-fold in Trps1−/− growth plate chondrocytes
(Fig. 5A), while expression of the anti-apoptotic proteins Bcl-
XL and FLIP was normal (data not shown).
To test the functional significance of the reduced activity of
caspase-3 and increased expression of the anti-apoptotic protein
Bcl-2, we induced apoptosis in cultured primary chondrocytes
Fig. 3. Chondrocyte proliferation is regulated by Trps1. (A) Consecutive sections of newborn knee joints were stained with an anti-BrdU antibody. (B) The numbers of
BrdU-positive and -negative chondrocytes were counted. The ratio of positive to total chondrocytes is significantly decreased in Trps1−/− epiphyses as compared to
wild-type counterparts (pb0.01). (C) Western blot analysis of cyclin D1 with extracted protein from epiphyseal cartilage (epi) and rib cartilage (rib) of wild-type (+/+)
and mutant (−/−) mice. Numbers represent relative intensity to that of wild-type. (D) Immunohistochemistry of cyclin D1 in proliferative zone of wild-type (+/+) and
mutant (−/−) growth plate. The immunoreaction (red) is seen in the proliferative chondrocytes. Nuclei were stained with DAPI (blue). (E) Northern blot analysis
showing that ATDC5 cells transfected with a CMV promoter-driven Trps1 cDNA construct (tg) express a higher amount of Trps1 mRNA. ctrl: ATDC5 cells
transfected with a CMV promoter vector only. (F) BrdU incorporation as determined by cell proliferation of ATDC5 cells with a vector only (wt) and a CMV promoter-
driven Trps1 cDNA construct (tg). ATDC5 cells with the initial cell number of 102 and 103 were used for the assay. Results represent means±standard deviation of four
samples.
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Subsequent TUNEL assays showed that Trps1−/− chondrocytes
were significantly less prone to apoptosis than wild-type
chondrocytes (Fig. 4B). In line with these findings, Trps1-
overexpressing ATDC5 chondrocyte cells treated with Jo2
antibodies exhibited a significantly increased apoptosis rate
(Fig. 4C) and decreased levels of Bcl-2 (Fig. 5C) when
compared to mock-transfected cells. These data suggest that
Trps1 can regulates chondrocytes proliferation and promote
their apoptosis by modulating Bcl-2 levels.
Trps1 regulates proliferation and apoptosis through Stat3
Proliferation of growth plate chondrocytes is regulated by
various external signals such as growth factors, hormones and
cytokines (for a review, see Karsenty andWagner, 2002). To test
whether their expression is altered we performed a series of in
situ hybridization of E15.5 tibial sections and found that the
expression of Fgf receptors 1, 2 and 3, Fgf 9, Fgf 18, Bmp 2 andBmp 4 were indistinguishable between wild-type and mutant
tissues (data not shown).
Recent findings demonstrated that overexpression of Stat3 in
liver is sufficient to increase Bcl-2 and support hepatocyte
survival (Haga et al., 2003). Since Trps1−/− chondrocytes were
less prone to apoptosis (Fig. 4A) and their Bcl-2 levels were
increased (Fig. 5A), we examined the expression of Stat3 in
mutant chondrocytes. Interestingly, Trps1−/− chondrocytes had
increased levels of total and phosphorylated Stat3 when
compared with wild-type chondrocytes (Fig. 5A). Immunohis-
tochemistry revealed an elevated number of chondrocytes with
nuclear phospho-Stat3 in Trps1−/− growth plates (Fig. 5B),
while the expression of other Stats including Stat1 and Stat5
were not changed (data not shown). Since overexpression of
Trps1 in ATDC5 chondrocytes decreased the levels and activity
of Stat3 (Fig. 5C) we conclude that Trps1 may act as a
transcriptional repressor of the Stat3 gene in chondrocytes.
To test whether Stat3 acts downstream of Trps1 in chon-
drocytes we depleted Sat3 expression using specific siRNA.
Fig. 4. Trps1 regulates apoptosis of chondrocytes. (A) TUNEL staining for the hypertrophic chondrocytes of the growth plate from newborn wild-type (+/+) and
mutant (−/−) mice. The number of TUNEL-positive cells is less in mutant mice (−/−) as compared to wild-type mice (+/+) (pb0.01). DAPI (blue) was used for nuclear
staining. (B) TUNEL staining of primary chondrocyte cell culture from wild-type (+/+) and mutant (−/−) mice. Apoptosis was induced by treatment with Jo2
antibodies. The ratio of TUNEL-positive cells to the total cells is increased in mutant (−/−) chondrocytes as compared to wild-type (−/−) counterparts (pb0.01). (C)
TUNEL staining of ATDC5 cells with a vector only (ctrl) and a CMV promoter-Trps1 cDNA construct (tg). Note that the ratio of TUNEL-positive cells is clearly
increased upon overexpression as compared to control (pb0.01).
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of the Stat3 protein, while control siRNAs neither affected Stat3
levels nor phosphorylation (Fig. 5D). Interestingly, depletion of
Stat3 reversed the Trps1−/− phenotype and increased cyclin D1
and decreased Bcl-2 levels (Fig. 5D).
To further confirm the function of Stat3 on proliferation and
apoptosis in chondrocytes we overexpressed a constitutively
activated form of Stat3 (Stat3-CA) in ATDC5 cells. This led to 3-
fold elevation of Bcl-2 and a 50% decrease in cyclin D1
expression (Fig. 5E). Moreover, Stat3-CA expressing ATDC5
cells displayed a significantly reduced proliferation rate (Fig.
5F). Together these data indicate that Trps1 regulates prolifera-
tion and apoptosis of chondrocytes by suppressing Stat3
signaling.
Trps1 regulates the expression of Stat3 gene via GATA sites in
the promoter region
The upregulation of Stat3 in Trps1−/− chondrocytes suggests
that Trps1 is suppressing transcription of the Stat3 gene by
directly binding to the Stat3 promoter region. The Stat3
promoter region contains two putative GATA sequences (Shi
et al., 1996) and therefore we next investigated whether one orboth of them are responsible for the suppression of Stat3
transcription. We constructed luciferase reporter constructs, in
which the Stat3 promoter region harbored mutations in either
one or both GATA sequences and expressed them in control
and Trps1−/− chondrocytes. As shown in Fig. 6A, luciferase
activity was significantly reduced in wild-type compared to
Trps1−/− chondrocytes. Ablation of either GATA site increased
luciferase activity 3-fold in wild-type chondrocytes (Fig. 6A)
indicating that both GATA sites are essential to suppress Stat3
transcription.
Next we performed chromatin immunoprecipitation (ChIP)
to show that Trps1 binds to the GATA sites in the Stat3
promoter. The assay revealed that we could immunoprecipitate
the GATA sites with anti-Trps1 antibodies in wild-type
chondrocytes (Fig. 6B), while neither immunoprecipitation
with control IgGs nor genomic DNA from Trps1−/− chondro-
cytes produced the expected PCR product (Fig. 6B).
Discussion
Mutations in the TRPS1 gene cause tricho-rhino-phalangeal
syndromes, which are characterized by hair, craniofacial
and skeletal abnormalities (Momeni et al., 2000). TRPS1 is a
Fig. 5. Ablation of Trps1 leads to an increased levels of Stat3 and phosphorylated Stat3. (A) Western blot analyses of Stat3, phosphorylated Stat3, cleaved caspase-3,
and Bcl-2 with cell extracts of primary chondrocytes from epiphyses (epi) and rib cartilage (rib) of wild-type (+/+) and mutant (−/−) mice. Number represents relative
intensity to that of wild type. (B) The localization of phosphorylated Stat3 in epiphyseal cartilage from wild-type (+/+) and mutant (−/−) mice (top). Translocation of
phosphorylated Stat3 (red) in growth plate chondrocytes from wild-type (+/+) and mutant (−/−) mice (bottom). Nuclei were stained with DAPI (blue). Note that
translocated Stat3 is seen in pink (arrow heads) because red color is superimposed on blue color. (C) Western blot analysis of Stat3, phosphorylated Stat3, cyclin D1,
and Bcl-2 with cell extract from control (ctrl) and Trps1 overexpressing (tg) ATDC5 cells. Number represents relative intensity to that of ctrl. (D) Knockdown of Stat3
in mutant chondrocytes using Stat3 siRNAs. Western blots were performed with cell extract of the primary chondrocytes from mutant epiphyseal cartilage. Stealth
double-strand siRNA (Invitrogen) was used as a control (ctrl). Number represents relative intensity to that of ctrl. (E) Western blot analysis of phosphorylated Stat3,
cyclin D1, and Bcl-2 with cell extracts from ATDC5 cells infected with an adenovirus vector only (ctrl) and one with a constitutively active Stat3 (Stat3-CA),
respectively. (F) Cell proliferation assay of ATDC5 cells infected with an adenovirus vector only (ctrl) and one with a constitutively active Stat3 (Stat3-CA).
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shown to bind GATA sequences and repress gene transcription
(Malik et al., 2001). To test the functional properties of the
GATA-type zinc finger motif Malik et al. (2002) engineered
mice, which expressed a GATA-type zinc finger-deficient Trps1
protein (Trps1Δgt). They found that heterozygous Trps1+/Δgt
mice are fertile, develop structural deficits in cortical and
trabecular bones and display facial abnormalities that resemble
TRPS I patients. Homozygous Trps1Δgt/Δgt mice die perinatally
of respiratory failure and have pronounced hair follicle defects.
Although this study directly assigns an important role of Trps1
for skeletal and hair follicle development, it did not show how
Trps1 regulates skeletal development at the molecular level. In
the present paper we generated Trps1-deficient mice to address
this question.
We ablated the Trps1 gene by disrupting the ATG-containing
exon 3 and found that heterozygous mice (Trps1+/−) have
reduced number of hair follicles in their back skin but otherwise
develop and age normally. The abnormalities in Trps1+/− mice
are restricted to the hair coat of the back and are less pronouncedthan in Trps1+/Δgt mice (Malik et al., 2002). An explanation for
the different severity could be that a GATA-deficient Trps1
expressed from the Trps1Δgt allele is more efficiently
antagonizing the wild-type Trps1 than the short N-terminal,
282 amino acid long polypeptide produced in our Trps1+/−
mice.
The Trps1−/− mice die perinatally of respiratory distress
likely caused by the absent cartilage plates in bronchi and
display pronounced skeletal and hair follicle defects. The
skeletal abnormalities range from growth retardation to skeletal
and facial abnormalities and closely resemble the abnormalities
seen in TRPS patients. The growth retardation was visible at
birth, affected the longitudinal growth all long bones and was
associated with abnormal growth plate morphology including
an extended length and narrowing of mutant growth plates, a
significantly reduced number of cells with an abnormal shape in
the proliferative zone and a normal number of cells in the
hypertrophic zone. We do not know the reason for the increased
length of Trps1−/− growth plates despite the severely reduced
cellularity in the proliferative zone. A possible explanation
Fig. 6. Transcriptional regulation of Stat3 by Trps1. (A) Mutation analysis of the Stat3 promoter using the luciferase reporter. Transactivation of Stat3 luciferase
reporter constructs with either wild-type (1) or mutant (2–4) GATA-binding sites (left panel) in wild-type or mutant chondrocytes. (1) Wild-type Stat3 promoter
construct, (2) mutant construct with a mutation in the upstream GATA site, (3) mutant construct with a mutation in the downstream GATA site, (4) mutant construct
with a mutation in both the upstream and downstream GATA sites. (B) Chromatin immunoprecipitation (ChIP) assay. PCR amplification of DNA fragments with
GATA site is shown. DNA templates were prepared from wild-type (+/+) and mutant (−/−) chondrocytes.
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pression of cartilage matrix proteins, or integrin-mediated
adhesion and/or the organization of the cytoskeleton, which are
known to profoundly affect chondrocytes shape and growth
plate morphology (Aszodi et al., 2003). Alternatively, the strong
expression of Trps1 in the perichondrial chondroblasts may be
critically important for appositional chondrogenesis and the
widening of growth plates. These possibilities are investigated
at the moment.
In search for a mechanistic explanation for the decreased
number of proliferating chondrocytes in Trps1−/− growth plates
we identified a signaling pathway, in which Trps1 undertakes
the principal task to bind both GATA sequences in the Stat3
promoter and then represses Stat3 transcription, which in turn is
enhancing cyclin D1 expression. The following evidence
supports this notion: first, we observed that Trps1−/− chon-
drocytes express significantly elevated levels of total and
phosphorylated Stat3 and dramatically reduced levels of cyclin
D1. Stat3 is known to regulate proliferation with different
outcomes depending on the cell type (for a review, see Levy and
Lee, 2002). In a pro-B cell line and in several breast and ovarian
cancer cells Stat3 was shown to trigger cyclin D1 expression
and the G1 to S phase transition (Fukada et al., 1998; Li et al.,
2004), while in granulocytes and hepatocytes Stat3 represses
cyclin D1 expression and negatively regulates cell proliferation
(Lee et al., 2002; Matsui et al., 2002). Second, siRNA-mediated
depletion of Stat3 in primary Trps1−/− chondrocytes restores
cyclin D1 to normal levels. Conversely, adenoviral over-
expression of constitutively activated Stat3 in the chondrogenic
ATDC5 cells induces a dramatic downregulation of cyclin
D1 expression and diminishes their proliferation rate. Third,
the activity of a Stat3 promoter-driven luciferase reporter isrepressed in wild-type chondrocytes. The repression is ef-
ficiently relieved upon mutation of either of the two or both
GATA sequences in the Stat3 promoter. Finally, chromatin
immunoprecipitation assays revealed that Trps1 is bound to the
upstream as well as downstream GATA sequence.
We also made the surprising observation that despite reduced
cellularity in the proliferative zones of Trps1−/− growth plates
the number of cells in hypertrophic zones was unaffected.
Hypertrophic chondrocytes are eliminated at the chondro-
osseous interzone by apoptosis (Shapiro et al., 2005). The
signaling pathway leading to apoptosis is not known. In line
with an important role of Trps1 in regulating apoptosis of
hypertrophic chondrocytes, we observed a significantly reduced
number of TUNEL-positive cells in the hypertrophic zone of
Trps1−/−mice and observed that primary Trps1−/− chondrocytes
are resistant to the apoptosis-inducing action of the agonistic
anti-Fas antibody Jo2. The high level and activity of Stat3 in
Trps1−/− chondrocytes together with the well documented role
of Stat3 as a survival promoting signaling molecule (Levy and
Lee, 2002) made Stat3 an obvious candidate for controlling
chondrocyte survival downstream of Trps1. This assumption
was corroborated with several experiments. Immunostaining of
wild-type growth plates revealed that Stat3 signals are gradually
disappearing when chondrocytes become hypertrophic and are
absent at the chondro-osseous interzone where cells apoptose.
In sharp contrast, Trps1−/− growth plate chondrocytes display
an intense phosphorylated Stat3 staining, which extends into the
hypertrophic zone. Interestingly, Western blot assays revealed
that the elevated levels of phosphorylated Stat3 in Trps1−/−
chondrocytes are associated with an elevation of Bcl-2
suggesting that Stat3 may act, at least in part, in a Bcl-2-
dependent manner (Takeda et al., 1998; Oritani et al., 1999).
581H. Suemoto et al. / Developmental Biology 312 (2007) 572–581This seems clearly to be the case since (i) the elevated Bcl-2
expression is restored to normal levels by siRNA-mediated
depletion of Stat3 in Trps1−/− chondrocytes, (ii) overexpression
of Stat3 in ATDC5 cells is increasing Bcl-2, and (iii)
overexpression of Trps1 in ATDC5 cells leads to a decrease
in Bcl-2 expression and apoptosis.
It is possible that also Stat3/Bcl-2-independent mechanisms
contribute to increased hypertrophic chondrocyte survival in
Trps1−/− growth plates. The absence of Trps1 from the chondro-
osseous interzone, however, excludes a potential pro-survival
role for Trps1 interacting proteins such as the transcriptional co-
activator RNF4 (Kaiser et al., 2003a) or dynein light chain
LC8a (Kaiser et al., 2003b), which blocks Bcl-2 activity by
binding the Bcl-2 family member Bim (Puthalakath et al.,
1999).
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